MAO-B inhibitors: Mptp is converted to mpp+ in the mitochondria of glial cells. The formation of the toxic mpp+ can be prevented by the use of mono-amine oxidase b inhibitor like selegeline which is used in the treatment of parkinson's disease. The chlorinated intermediate of mpp+ has been used as a pesticide (paraquat) to prevent the formation of the reactive, free radical generating mpp+ avoid it.
Answered 5/7/2014
4.1k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 3 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question